カテゴリー： GlobalInfoResearch, 世界

成人および小児用ワクチンの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Adult and Pediatric Vaccines Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9102921）・商品コード：GIR9102921
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月23日（※2024年版があります。お問い合わせください）
・ページ数：115
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、成人および小児用ワクチンの世界市場について調べ、まとめました。種類別セグメントは、成人用ワクチン、小児用ワクチン等、用途別セグメントは、病院、医療センター、その他等に区分しました。成人および小児用ワクチンの世界市場概観、企業動向、企業別成人および小児用ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・成人および小児用ワクチンの市場概観
・成人および小児用ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・成人および小児用ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向
・成人および小児用ワクチンの世界市場規模
・成人および小児用ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等）
・成人および小児用ワクチンのアメリカ市場規模推移
・成人および小児用ワクチンのカナダ市場規模推移
・成人および小児用ワクチンのメキシコ市場規模推移
・成人および小児用ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・成人および小児用ワクチンのドイツ市場規模推移
・成人および小児用ワクチンのイギリス市場規模推移
・成人および小児用ワクチンのロシア市場規模推移
・成人および小児用ワクチンのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・成人および小児用ワクチンの日本市場規模推移
・成人および小児用ワクチンの中国市場規模推移
・成人および小児用ワクチンの韓国市場規模推移
・成人および小児用ワクチンのインド市場規模推移
・成人および小児用ワクチンの東南アジア市場規模推移
・成人および小児用ワクチンの南米市場分析（ブラジル、アルゼンチン等）
・成人および小児用ワクチンの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・成人および小児用ワクチンの種類別分析/販売量、売上、市場シェア（成人用ワクチン、小児用ワクチン）
・成人および小児用ワクチンの用途別分析/市場規模（病院、医療センター、その他）
・成人および小児用ワクチンの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・成人および小児用ワクチンの販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

A vaccine is a biological preparation that provides active acquired immunity to a particular disease.

Scope of the Report:
The global Adult and Pediatric Vaccines market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Adult and Pediatric Vaccines.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Adult and Pediatric Vaccines market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Adult and Pediatric Vaccines market by product type and applications/end industries.

Market Segment by Companies, this report covers
GlaxoSmithKline
Sanofi
Merck
Novartis
Pfizer
AstraZeneca
Johnson and Johnson
Takeda Pharmaceutical
Bavarian Nordic
LG Life Sciences
Sinovac Biotech

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Adult Vaccines
Pediatric Vaccines

Market Segment by Applications, can be divided into
Hospitals
Medical Care Centers
Others

【レポートの目次】

Table of Contents

1 Adult and Pediatric Vaccines Market Overview
1.1 Product Overview and Scope of Adult and Pediatric Vaccines
1.2 Classification of Adult and Pediatric Vaccines by Types
1.2.1 Global Adult and Pediatric Vaccines Revenue Comparison by Types (2019-2024)
1.2.2 Global Adult and Pediatric Vaccines Revenue Market Share by Types in 2018
1.2.3 Adult Vaccines
1.2.4 Pediatric Vaccines
1.3 Global Adult and Pediatric Vaccines Market by Application
1.3.1 Global Adult and Pediatric Vaccines Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Medical Care Centers
1.3.4 Others
1.4 Global Adult and Pediatric Vaccines Market by Regions
1.4.1 Global Adult and Pediatric Vaccines Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Adult and Pediatric Vaccines Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Adult and Pediatric Vaccines Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Adult and Pediatric Vaccines Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Adult and Pediatric Vaccines Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Adult and Pediatric Vaccines Status and Prospect (2014-2024)
1.5 Global Market Size of Adult and Pediatric Vaccines (2014-2024)
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 Business Overview
2.1.2 Adult and Pediatric Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Adult and Pediatric Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
2.3 Merck
2.3.1 Business Overview
2.3.2 Adult and Pediatric Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Adult and Pediatric Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Adult and Pediatric Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
2.6 AstraZeneca
2.6.1 Business Overview
2.6.2 Adult and Pediatric Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AstraZeneca Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
2.7 Johnson and Johnson
2.7.1 Business Overview
2.7.2 Adult and Pediatric Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Johnson and Johnson Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
2.8 Takeda Pharmaceutical
2.8.1 Business Overview
2.8.2 Adult and Pediatric Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
2.9 Bavarian Nordic
2.9.1 Business Overview
2.9.2 Adult and Pediatric Vaccines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bavarian Nordic Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
2.10 LG Life Sciences
2.10.1 Business Overview
2.10.2 Adult and Pediatric Vaccines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 LG Life Sciences Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
2.11 Sinovac Biotech
2.11.1 Business Overview
2.11.2 Adult and Pediatric Vaccines Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sinovac Biotech Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
3 Global Adult and Pediatric Vaccines Market Competition, by Players
3.1 Global Adult and Pediatric Vaccines Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Adult and Pediatric Vaccines Players Market Share
3.2.2 Top 10 Adult and Pediatric Vaccines Players Market Share
3.3 Market Competition Trend
4 Global Adult and Pediatric Vaccines Market Size by Regions
4.1 Global Adult and Pediatric Vaccines Revenue and Market Share by Regions
4.2 North America Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
4.3 Europe Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
4.5 South America Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
5 North America Adult and Pediatric Vaccines Revenue by Countries
5.1 North America Adult and Pediatric Vaccines Revenue by Countries (2014-2019)
5.2 USA Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
5.3 Canada Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
5.4 Mexico Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
6 Europe Adult and Pediatric Vaccines Revenue by Countries
6.1 Europe Adult and Pediatric Vaccines Revenue by Countries (2014-2019)
6.2 Germany Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
6.3 UK Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
6.4 France Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
6.5 Russia Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
6.6 Italy Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Adult and Pediatric Vaccines Revenue by Countries
7.1 Asia-Pacific Adult and Pediatric Vaccines Revenue by Countries (2014-2019)
7.2 China Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
7.3 Japan Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
7.4 Korea Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
7.5 India Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
8 South America Adult and Pediatric Vaccines Revenue by Countries
8.1 South America Adult and Pediatric Vaccines Revenue by Countries (2014-2019)
8.2 Brazil Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
8.3 Argentina Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
8.4 Colombia Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Adult and Pediatric Vaccines by Countries
9.1 Middle East and Africa Adult and Pediatric Vaccines Revenue by Countries (2014-2019)
9.2 Saudi Arabia Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
9.3 UAE Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
9.4 Egypt Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
9.5 Nigeria Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
9.6 South Africa Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
10 Global Adult and Pediatric Vaccines Market Segment by Type
10.1 Global Adult and Pediatric Vaccines Revenue and Market Share by Type (2014-2019)
10.2 Global Adult and Pediatric Vaccines Market Forecast by Type (2019-2024)
10.3 Adult Vaccines Revenue Growth Rate (2014-2024)
10.4 Pediatric Vaccines Revenue Growth Rate (2014-2024)
11 Global Adult and Pediatric Vaccines Market Segment by Application
11.1 Global Adult and Pediatric Vaccines Revenue Market Share by Application (2014-2019)
11.2 Adult and Pediatric Vaccines Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Medical Care Centers Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Adult and Pediatric Vaccines Market Size Forecast (2019-2024)
12.1 Global Adult and Pediatric Vaccines Market Size Forecast (2019-2024)
12.2 Global Adult and Pediatric Vaccines Market Forecast by Regions (2019-2024)
12.3 North America Adult and Pediatric Vaccines Revenue Market Forecast (2019-2024)
12.4 Europe Adult and Pediatric Vaccines Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Adult and Pediatric Vaccines Revenue Market Forecast (2019-2024)
12.6 South America Adult and Pediatric Vaccines Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Adult and Pediatric Vaccines Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Adult and Pediatric Vaccines Picture
Table Product Specifications of Adult and Pediatric Vaccines
Table Global Adult and Pediatric Vaccines and Revenue (Million USD) Market Split by Product Type
Figure Global Adult and Pediatric Vaccines Revenue Market Share by Types in 2018
Figure Adult Vaccines Picture
Figure Pediatric Vaccines Picture
Table Global Adult and Pediatric Vaccines Revenue (Million USD) by Application (2014-2024)
Figure Adult and Pediatric Vaccines Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Medical Care Centers Picture
Figure Others Picture
Table Global Market Adult and Pediatric Vaccines Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Adult and Pediatric Vaccines Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Adult and Pediatric Vaccines Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Adult and Pediatric Vaccines Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Adult and Pediatric Vaccines Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Adult and Pediatric Vaccines Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Adult and Pediatric Vaccines Revenue (Million USD) and Growth Rate (2014-2024)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Adult and Pediatric Vaccines Type and Applications
Table GlaxoSmithKline Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Adult and Pediatric Vaccines Type and Applications
Table Sanofi Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Adult and Pediatric Vaccines Type and Applications
Table Merck Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Adult and Pediatric Vaccines Type and Applications
Table Novartis Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Adult and Pediatric Vaccines Type and Applications
Table Pfizer Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Adult and Pediatric Vaccines Type and Applications
Table AstraZeneca Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson and Johnson Adult and Pediatric Vaccines Type and Applications
Table Johnson and Johnson Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Adult and Pediatric Vaccines Type and Applications
Table Takeda Pharmaceutical Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table Bavarian Nordic Adult and Pediatric Vaccines Type and Applications
Table Bavarian Nordic Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table LG Life Sciences Adult and Pediatric Vaccines Type and Applications
Table LG Life Sciences Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table Sinovac Biotech Basic Information, Manufacturing Base and Competitors
Table Sinovac Biotech Adult and Pediatric Vaccines Type and Applications
Table Sinovac Biotech Adult and Pediatric Vaccines Revenue, Gross Margin and Market Share (2017-2018)
Table Global Adult and Pediatric Vaccines Revenue (Million USD) by Players (2014-2019)
Table Global Adult and Pediatric Vaccines Revenue Share by Players (2014-2019)
Figure Global Adult and Pediatric Vaccines Revenue Share by Players in 2017
Figure Global Adult and Pediatric Vaccines Revenue Share by Players in 2018
Figure Global Top 5 Players Adult and Pediatric Vaccines Revenue Market Share in 2018
Figure Global Top 10 Players Adult and Pediatric Vaccines Revenue Market Share in 2018
Figure Global Adult and Pediatric Vaccines Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Adult and Pediatric Vaccines Revenue (Million USD) by Regions (2014-2019)
Table Global Adult and Pediatric Vaccines Revenue Market Share by Regions (2014-2019)
Figure Global Adult and Pediatric Vaccines Revenue Market Share by Regions (2014-2019)
Figure Global Adult and Pediatric Vaccines Revenue Market Share by Regions in 2018
Figure North America Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure Europe Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure South America Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Table North America Adult and Pediatric Vaccines Revenue by Countries (2014-2019)
Table North America Adult and Pediatric Vaccines Revenue Market Share by Countries (2014-2019)
Figure North America Adult and Pediatric Vaccines Revenue Market Share by Countries (2014-2019)
Figure North America Adult and Pediatric Vaccines Revenue Market Share by Countries in 2018
Figure USA Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure Canada Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure Mexico Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Table Europe Adult and Pediatric Vaccines Revenue (Million USD) by Countries (2014-2019)
Figure Europe Adult and Pediatric Vaccines Revenue Market Share by Countries (2014-2019)
Figure Europe Adult and Pediatric Vaccines Revenue Market Share by Countries in 2018
Figure Germany Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure UK Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure France Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure Russia Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure Italy Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Adult and Pediatric Vaccines Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Adult and Pediatric Vaccines Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Adult and Pediatric Vaccines Revenue Market Share by Countries in 2018
Figure China Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure Japan Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure Korea Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure India Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Table South America Adult and Pediatric Vaccines Revenue by Countries (2014-2019)
Table South America Adult and Pediatric Vaccines Revenue Market Share by Countries (2014-2019)
Figure South America Adult and Pediatric Vaccines Revenue Market Share by Countries (2014-2019)
Figure South America Adult and Pediatric Vaccines Revenue Market Share by Countries in 2018
Figure Brazil Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure Argentina Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure Colombia Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Adult and Pediatric Vaccines Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Adult and Pediatric Vaccines Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Adult and Pediatric Vaccines Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Adult and Pediatric Vaccines Revenue Market Share by Countries in 2018
Figure Saudi Arabia Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure UAE Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure Egypt Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure Nigeria Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Figure South Africa Adult and Pediatric Vaccines Revenue and Growth Rate (2014-2019)
Table Global Adult and Pediatric Vaccines Revenue (Million USD) by Type (2014-2019)
Table Global Adult and Pediatric Vaccines Revenue Share by Type (2014-2019)
Figure Global Adult and Pediatric Vaccines Revenue Share by Type (2014-2019)
Figure Global Adult and Pediatric Vaccines Revenue Share by Type in 2019
Table Global Adult and Pediatric Vaccines Revenue Forecast by Type (2019-2024)
Figure Global Adult and Pediatric Vaccines Market Share Forecast by Type (2019-2024)
Figure Global Adult Vaccines Revenue Growth Rate (2014-2019)
Figure Global Pediatric Vaccines Revenue Growth Rate (2014-2019)
Table Global Adult and Pediatric Vaccines Revenue by Application (2014-2019)
Table Global Adult and Pediatric Vaccines Revenue Share by Application (2014-2019)
Figure Global Adult and Pediatric Vaccines Revenue Share by Application (2014-2019)
Figure Global Adult and Pediatric Vaccines Revenue Share by Application in 2019
Table Global Adult and Pediatric Vaccines Revenue Forecast by Application (2019-2024)
Figure Global Adult and Pediatric Vaccines Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Medical Care Centers Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Adult and Pediatric Vaccines Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Adult and Pediatric Vaccines Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Adult and Pediatric Vaccines Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Adult and Pediatric Vaccines Revenue Market Forecast (2019-2024)
Figure Europe Adult and Pediatric Vaccines Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Adult and Pediatric Vaccines Revenue Market Forecast (2019-2024)
Figure South America Adult and Pediatric Vaccines Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Adult and Pediatric Vaccines Revenue Market Forecast (2019-2024)


【掲載企業】

GlaxoSmithKline、Sanofi、Merck、Novartis、Pfizer、AstraZeneca、Johnson and Johnson、Takeda Pharmaceutical、Bavarian Nordic、LG Life Sciences、Sinovac Biotech、

★調査レポート[成人および小児用ワクチンの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9102921)販売に関する免責事項を必ずご確認ください。
★調査レポート[成人および小児用ワクチンの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 組換えベクターワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101143 / GlobalInfoResearch / 2019年9月9日 / 本調査レポートは、組換えベクターワクチンの世界市場について調べ、まとめました。種類別セグメントは、水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、その他等、用途別セグメントは、大人用、子供用等に区分しました。組換えベクターワクチンの世界市場概観、メーカー動向、メーカー別組換えベクターワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・組換えベクターワクチンの市場概観 ・組換えベクターワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・組換えベクターワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・組換えベクターワクチンの世界市場規模 ・組換えベクターワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・組換えベクターワクチンのアメリカ市場規模推移 ・組換えベクターワクチンのカナダ市場規模推移 ・組換えベクターワクチンのメキシコ市場規模推移 ・組換えベクターワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Recombinant vector vaccines are experimental vaccines similar to DNA vaccines, but they use an attenuated virus or bacterium to introduce microbial DNA to cells of the body. “Vector” refers to the virus or bacterium used as the carrier. In nature, viruses latch on to cells and inject their genetic material into them. In the lab, scientists have taken advantage of this process. They have figured out how to take the roomy genomes of certain harmless or attenuated viruses and insert portions of the genetic material from other microbes into them. The carrier viruses then ferry that microbial DNA to cells....
  • バイオ医薬品およびワクチンの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102920 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、バイオ医薬品およびワクチンの世界市場について調べ、まとめました。種類別セグメントは、バイオ医薬品、ワクチン製造等、用途別セグメントは、製薬産業、臨床診断、科学研究、その他等に区分しました。バイオ医薬品およびワクチンの世界市場概観、企業動向、企業別バイオ医薬品およびワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・バイオ医薬品およびワクチンの市場概観 ・バイオ医薬品およびワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・バイオ医薬品およびワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・バイオ医薬品およびワクチンの世界市場規模 ・バイオ医薬品およびワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・バイオ医薬品およびワクチンのアメリカ市場規模推移 ・バイオ医薬品およびワクチンのカナダ市場規模推移 ・バイオ医薬品およびワクチンのメキシコ市場規模推移 ・バイオ医薬品およびワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Biopharmaceuticals and vaccines are well recognized for their potential in treating incurable diseases for which conventional low-molecular-weight pharmaceuticals produced by chemical synthesis are ineffective and for preventing infectious diseases. Scope of the Report: The global Biopharmaceutical and Vaccines market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still...
  • 猫用ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101182 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、猫用ワクチンの世界市場について調べ、まとめました。種類別セグメントは、弱毒生ワクチン、コンジュゲートワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、組換えワクチン等、用途別セグメントは、＜6ヶ月、≥6ヶ月等に区分しました。猫用ワクチンの世界市場概観、メーカー動向、メーカー別猫用ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・猫用ワクチンの市場概観 ・猫用ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・猫用ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・猫用ワクチンの世界市場規模 ・猫用ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・猫用ワクチンのアメリカ市場規模推移 ・猫用ワクチンのカナダ市場規模推移 ・猫用ワクチンのメキシコ市場規模推移 ・猫用ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Vaccines are kins of Vaccines for cats Scope of the Report: The worldwide market for Cat Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study....
  • 犬用ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101183 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、犬用ワクチンの世界市場について調べ、まとめました。種類別セグメントは、弱毒生ワクチン、コンジュゲートワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、DNAワクチン、組換えワクチン等、用途別セグメントは、...A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.Cat Vaccines are kins of Vaccines for dogs Scope of the Report: The worldwide market for Dog Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study....
  • 小児用ストレッチャーの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103389 / GlobalInfoResearch / 2019年9月26日 / 本調査レポートは、小児用ストレッチャーの世界市場について調べ、まとめました。種類別セグメントは、固定ストレッチャー、調整可能なストレッチャー、ストレッチャーチェアー等、用途別セグメントは、病院、診療所および救急車施設等に区分しました。小児用ストレッチャーの世界市場概観、メーカー動向、メーカー別小児用ストレッチャーシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・小児用ストレッチャーの市場概観 ・小児用ストレッチャーの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・小児用ストレッチャーの企業別販売動向、市場シェア、市場集中度、競争動向 ・小児用ストレッチャーの世界市場規模 ・小児用ストレッチャーの北米市場分析（アメリカ、カナダ、メキシコ等） ・小児用ストレッチャーのアメリカ市場規模推移 ・小児用ストレッチャーのカナダ市場規模推移 ・小児用ストレッチャーのメキシコ市場規模推移 ・小児用ストレッチャーのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Today's medical stretchers serve a vital purpose in the health care field: to safely and securely convey injured patients through hospitals, private practices, and clinics. Hospital stretchers are also used by emergency medical technicians to transport the critically injured into emergency rooms. Patients undergoing operative procedures are brought from operating rooms into recovery areas on transport stretchers. Pediatric Stretchers are the stretchers used for pediatric. Scope of the Report: The worldwide market for Pediatric Stretchers is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$...
  • 小児ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100436 / GlobalInfoResearch / 2019年10月11日 / 本調査レポートは、小児ワクチンの世界市場について調べ、まとめました。種類別セグメントは、組換えワクチン、ウイルスワクチン、多糖ワクチン、その他等、用途別セグメントは、病院、クリニック等に区分しました。小児ワクチンの世界市場概観、メーカー動向、メーカー別小児ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・小児ワクチンの市場概観 ・小児ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・小児ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・小児ワクチンの世界市場規模 ・小児ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・小児ワクチンのアメリカ市場規模推移 ・小児ワクチンのカナダ市場規模推移 ・小児ワクチンのメキシコ市場規模推移 ・小児ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Childhood Vaccines is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Childhood Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers MedImmune LLC J&J(Crucell) Pfizer Sanofi GSK Merck Tiantan CSL Jintan...

    • ◆H&Iグローバルリサーチのお客様（例）◆